Back to top

SilverArc Capital Management Exits KalVista Pharmaceuticals (KALV) Position Entirely

SilverArc Capital Management Exits KalVista Pharmaceuticals (KALV) Position Entirely

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Ascendis Pharma A/S (ASND)

Celcuity, Inc. (CELC)

Cogent Biosciences, Inc. (COGT)

Immunome, Inc. (IMNM)

Urogen Pharma (URGN)